Peptide Biomarkers in Clinical Diagnostics

Peptides offer a rich view of disease biology that is unlocked by modern mass spectrometry, but how can we take them from discovery to clinical utility?

By
Compound Vitality Research Team
October 20, 2026
6 min

The Pathologist

1

Peptide patterns can reflect protein processing, protease activity, and tissue response, potentially adding biological specificity beyond measurements of protein abundance.
2

Mass spectrometry enables broad peptide profiling without requiring a separate antibody for each candidate, making it useful for biomarker discovery.
3

Peptide measurements are sensitive to specimen handling and analysis, so collection, storage, preparation, and reagent characterization require careful control.
4

MALDI-TOF studies reported informative serum peptide features and strong model discrimination for hepato-pancreato-biliary cancers, but these findings require further validation.
5

Clinical adoption requires reliable performance in independent cohorts and laboratories, with pathologists helping define intended use, comparison groups, and specimen context.

Peptide Biomarkers in Clinical Diagnostics

1

2

3

4

5

Original Source(s)

Peptide Biomarkers in Clinical Diagnostics

Related Content

Pericyte loss and endothelial activation define distinct vascular states in cerebral small vessel disease

Aptamer Tests Face the Validation Challenge

The Diagnosis Begins With You